Peter Goldstein
- Iliad Biotechnologies, LLC (no department on record)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10693426Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2024
Award data coverage
ScienceDex currently has one fiscal year of PI ranking data for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2024): $317.5K in linked award amounts across 1 award record · Award-linked rank #40304.
FY2024 award records by amount
NIH award records listing Peter Goldstein as a PI. Multi-PI records show the full award amount for context.
- 5R61AI169201-03R61Contact PILive nasal recombinant B. pertussis vaccine against tuberculosis$317.5Kaward amount
Award organization
Organizations that administered FY2024 awards listing Peter Goldstein as a PI.
FY2024 award administered by Iliad Biotechnologies, LLC (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardIliad Biotechnologies, LLC
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Peter Goldstein.